Cargando…
Covishield vaccine induces robust immune responses in Bangladeshi adults
OBJECTIVE: To evaluate severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)-specific antibody responses after Covishield vaccination for 6 months after vaccination. DESIGN: SARS-CoV-2-specific antibody responses were assessed by enzyme-linked immunosorbent assay of the recombinant receptor-b...
Autores principales: | Bhuiyan, Taufiqur Rahman, Akhtar, Marjahan, Khaton, Fatema, Rahman, Sadia Isfat Ara, Ferdous, Jannatul, Alamgir, A.S.M., Rahman, Mahbubur, Kawser, Zannat, Hasan, Imrul, Calderwood, Stephen Beaven, Harris, Jason B., Charles, Richelle C., LaRocque, Regina C., Ryan, Edward Thomas, Banu, Sayera, Shirin, Tahmina, Qadri, Firdausi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9050186/ https://www.ncbi.nlm.nih.gov/pubmed/35720155 http://dx.doi.org/10.1016/j.ijregi.2022.04.006 |
Ejemplares similares
-
Seroprevalence of SARS-CoV-2 antibodies in Bangladesh related to novel coronavirus infection
por: Bhuiyan, Taufiqur Rahman, et al.
Publicado: (2022) -
The Fatal Clinical Outcome of Severe COVID-19 in Hospitalized Patients: Findings from a Prospective Cohort Study in Dhaka, Bangladesh
por: Ahmed, Tasnuva, et al.
Publicado: (2023) -
Disease characteristics and serological responses in patients with differing severity of COVID-19 infection: A longitudinal cohort study in Dhaka, Bangladesh
por: Akter, Afroza, et al.
Publicado: (2022) -
Antibody responses after COVID-19 infection in patients who are mildly symptomatic or asymptomatic in Bangladesh
por: Shirin, Tahmina, et al.
Publicado: (2020) -
Determining clinical biomarkers to predict long-term SARS-CoV-2 antibody response among COVID-19 patients in Bangladesh
por: Ahmed, Tasnuva, et al.
Publicado: (2023)